Palisade Bio, Inc. (NASDAQ:PALI – Get Rating) was down 3% during mid-day trading on Tuesday . The company traded as low as $1.55 and last traded at $1.61. Approximately 514,994 shares traded hands during trading, a decline of 66% from the average daily volume of 1,512,302 shares. The stock had previously closed at $1.66. Analysts […]
Maxim Group upgraded shares of Palisade Bio (NASDAQ:PALI – Get Rating) from a hold rating to a buy rating in a research report released on Thursday morning, The Fly reports. Palisade Bio Stock Performance Shares of PALI opened at $3.52 on Thursday. The company has a market capitalization of $15.84 million, a price-to-earnings ratio of […]
Palisade Bio (NASDAQ:PALI – Get Rating) was upgraded by equities research analysts at Maxim Group from a “hold” rating to a “buy” rating in a note issued to investors on Thursday, The Fly reports. Palisade Bio Trading Up 5.7 % NASDAQ PALI opened at $1.68 on Thursday. Palisade Bio has a 1 year low of […]